Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-25-009568
Filing Date
2025-08-14
Accepted
2025-08-14 09:31:38
Documents
59
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cvm_10q.htm   iXBRL 10-Q 768601
2 CERTIFICATION cvm_ex31.htm EX-31 22484
3 CERTIFICATION cvm_ex32.htm EX-32 4820
9 cvm_10qimg7.jpg GRAPHIC 35880
10 cvm_10qimg1.jpg GRAPHIC 21028
11 cvm_10qimg2.jpg GRAPHIC 21288
12 cvm_10qimg3.jpg GRAPHIC 20018
13 cvm_10qimg4.jpg GRAPHIC 30772
14 cvm_10qimg5.jpg GRAPHIC 32117
15 cvm_10qimg6.jpg GRAPHIC 24389
  Complete submission text file 0001654954-25-009568.txt   4105996

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cvm-20250630.xsd EX-101.SCH 37539
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20250630_lab.xml EX-101.LAB 241391
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20250630_cal.xml EX-101.CAL 39642
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20250630_pre.xml EX-101.PRE 192077
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20250630_def.xml EX-101.DEF 88441
62 EXTRACTED XBRL INSTANCE DOCUMENT cvm_10q_htm.xml XML 477498
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-11889 | Film No.: 251214948
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)